Search This Blog

Monday, August 12, 2019

NGM Biopharmaceuticals EPS beats by $0.18, beats on revenue

NGM Biopharmaceuticals (NASDAQ:NGM): Q2 GAAP EPS of -$0.13 beats by $0.18.
Related party revenue of $25.34M (+14.6% Y/Y) beats by $3.65M.
Cash, cash equivalents and short-term marketable of $362.2M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)